Sale of 2,075 shares at $33.7556 per share.
Reporting Person Gault Cheryl · Officer Title Chief Operating Officer · Transaction Code S
Traded Sep 30, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001193125-26-410734 · filed 2026-10-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Rapport Therapeutics, Inc. (RAPP)." Disclosed 2026-10-01. https://desqlong.com/cards/0001193125-26-410734-2 (retrieved 2026-10-02).